Related Experiment Video
Updated: May 6, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Insulin administration and the impacts of forgetting a dose
Meryl Brod1, Betsy Pohlman, Jens Harald Kongsø
1The Brod Group, 219 Julia Avenue, Mill Valley, CA, USA, mbrod@thebrodgroup.net.
Purpose:
Little is known about unintentional non-adherence associated with forgetting insulin injections and dose amounts. The study objective was to qualitatively examine unintentional insulin dosing and injection irregularities due to forgetting among people with diabetes mellitus.
Methods:
Seven focus group interviews and eight telephone interviews were conducted in Canada, Germany, and China. Participants were required to have diabetes, and to have experienced at least two instances in the previous 3 months of forgetting their insulin injection, forgetting the time/amount taken, or questioning if they had taken their injection. Transcripts were coded thematically, based on a grounded theoretical approach.
Results:
Sixty-four patients participated: 34.4 % with type 1 diabetes and 65.6 % with type 2 diabetes. The mean age was 50.1 years (range, 18-72 years). The analysis included six domains: Forgetting, what people forgot; Reasons for forgetting; Realizing forgetting; Corrective actions; Consequences of forgetting; and Feelings about forgetting. Participants reported forgetting both bolus and basal insulin doses and often felt uncertain about whether, when, and how much insulin they had taken. The major reasons for forgetting were disruptions to their daily routine, distraction by social events, minor interruptions, and being busy. Participants employed a wide variety of strategies and corrective actions when they thought they had forgotten, and often worried as a result.
Conclusions:
Forgetting or questioning insulin dosing impacts insulin-taking behavior and contributes to patient uncertainty and worry about their diabetes management. Insulin strategies that assist patients in managing memory-related dosing issues may improve adherence or treatment outcomes.
More Related Videos
10:32Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Hypoglycemia and Glucagon
Dosage Interval and Administration Route: Determination Methods
Hypoglycemia
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...